Jupiter Neurosciences (JUNS) EPS (Basic) (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported EPS (Basic) for 4 consecutive years, with -$5.06 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EPS (Basic) rose 0.59% year-over-year to -$5.06 in Q2 2026; TTM through Jun 2026 was -$18.36, a 38.41% decrease from a year earlier, with the FY2025 full-year figure at -$19.44, down 123.74% from the prior year.
• EPS (Basic) was -$5.06 for Q2 2026 at Jupiter Neurosciences, up from -$6.22 in the prior quarter.
• Over five years, EPS (Basic) peaked at -$1.45 in Q3 2024 and troughed at -$6.22 in Q4 2025.
• A 4-year average of -$3.62 and a median of -$3.87 in 2024 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) jumped 66.46% in 2024 and sank 247.5% in 2025, its largest moves.
• Over 4 years, EPS (Basic) stood at -$1.81 in 2023, then sank by 113.19% to -$3.87 in 2024, then sank by 60.88% to -$6.22 in 2025, then increased by 18.59% to -$5.06 in 2026.
• The last three EPS (Basic) figures came in at -$5.06 (Q2 2026), -$6.22 (Q4 2025), and -$5.04 (Q3 2025), per Business Quant data.